Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2012
03/27/2012US8143058 Human CDR-grafted antibody and antibody fragment thereof
03/27/2012US8142784 Antibody-drug conjugates and methods
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142772 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
03/27/2012US8142770 Drug comprising as the active ingredient proliferative vector containing survivin promoter
03/27/2012CA2682329C Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
03/27/2012CA2603671C Insp163 polypeptides for the treatment or prevention of cancer and arthritis
03/27/2012CA2584482C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
03/27/2012CA2540541C Alkoxy substituted imidazoquinolines
03/27/2012CA2496203C Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
03/27/2012CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2435812C Process and compositions for peptide, protein and peptidomimetic synthesis
03/27/2012CA2421087C Antisense insulin-like growth factor binding protein (igfbp)-2 oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/27/2012CA2371922C Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/22/2012WO2012037553A2 Use of pkc-iota inhibitors for the treatment of breast cancer
03/22/2012WO2012037411A2 Estrogen receptor modulators and uses thereof
03/22/2012WO2012037410A2 Estrogen receptor modulators and uses thereof
03/22/2012WO2012037380A2 Formulations of guanylate cyclase c agonists and methods of use
03/22/2012WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012037155A2 Tyrosine kinase inhibitors
03/22/2012WO2012037132A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012WO2012037072A1 Hsp90 inhibitors for treating non-small cell lung cancers in wild-type egfr and/or kras patients
03/22/2012WO2012037060A1 Substituted azaindoles
03/22/2012WO2012037004A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/22/2012WO2012036412A2 Peptide having a vascularization-suppressing activity and a use therefor
03/22/2012WO2012036392A2 Human anti-epidermal growth factor receptor fab antibody and a pharmaceutical composition for treating tumours comprising the same
03/22/2012WO2012036287A1 Novel cortistatin a analog and use thereof
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012036180A1 Xanthone derivative and use thereof
03/22/2012WO2012036152A1 High purity heparin and production method therefor
03/22/2012WO2012035794A1 Octreotide-modified nano preparation for treatment of cancer or palliative care of cancer
03/22/2012WO2012035747A1 Cancer heat therapy-enhancing agent
03/22/2012WO2012035436A1 Plinabulin prodrug analogs and therapeutic uses thereof
03/22/2012WO2012035305A1 Bioactive alkaloids
03/22/2012WO2012035171A2 New compounds
03/22/2012WO2012035147A1 Nuclear export inhibitors
03/22/2012WO2012035131A1 Treatment of abl overexpressing b-cell lymphoma
03/22/2012WO2012035078A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
03/22/2012WO2012034969A1 Gt aptamer oligonucleotides and use thereof as antitumor agents
03/22/2012WO2012034954A1 Substituted hexahydropyrrolo [1, 2 - c] imidazolones useful as mdm2 inhibitors
03/22/2012WO2012034942A1 Compounds for the modulation of aurora kinase b expression
03/22/2012WO2012034540A1 Anti-tumor pharmaceutical composition
03/22/2012WO2012034526A1 Fused heteroaryls and their uses
03/22/2012WO2012034519A1 Tannin extract of sanguisorba officinalis l. and preparation method and use thereof
03/22/2012WO2012034363A1 Compounds of hedgehog pathway inhibitors, pharmaceutical compositions containing the same and uses thereof
03/22/2012WO2012006341A3 Anti-ron antibodies
03/22/2012WO2012001308A9 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials
03/22/2012WO2012001064A3 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
03/22/2012WO2011161631A3 Compounds for treatment of tumors bearing deregulated myc oncoproteins
03/22/2012WO2011149250A3 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases
03/22/2012WO2011133925A3 Targeted and light-activated cytosolic drug delivery
03/22/2012WO2011104490A3 Use of essential oil of oregano or of rosewood for the treatment of cancerous keratoses
03/22/2012WO2011104489A3 Use of essential oil of oregano or of rosewood in the treatment of actinic keratoses
03/22/2012US20120071859 Inducible interleukin-12
03/22/2012US20120071704 Mitochondrial localization of muc1
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071653 Human Adam-10 Inhibitors
03/22/2012US20120071559 METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG
03/22/2012US20120071554 Deuterated 2-propylpentanoic acid compounds
03/22/2012US20120071542 Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas
03/22/2012US20120071540 Compositions and Methods Using siRNA Molecules and siRNA Cocktails for the Treatment of Breast Cancer
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071532 Novel solid forms of bendamustine hydrochloride
03/22/2012US20120071527 Therapeutic compounds
03/22/2012US20120071524 Compounds for treatment of cancer
03/22/2012US20120071523 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/22/2012US20120071515 Nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
03/22/2012US20120071513 Compositions and Their Use as Anti-Tumor Agents
03/22/2012US20120071509 process
03/22/2012US20120071508 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53
03/22/2012US20120071507 Treatment regimen utilizing neratinib for breast cancer
03/22/2012US20120071505 Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071501 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
03/22/2012US20120071497 Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071492 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
03/22/2012US20120071491 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
03/22/2012US20120071490 P70 s6 kinase inhibitors
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071480 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
03/22/2012US20120071478 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071476 Morpholinopurine derivatives
03/22/2012US20120071474 Inhibitors of pi3 kinase
03/22/2012US20120071473 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071467 Amide derivative
03/22/2012US20120071465 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
03/22/2012US20120071454 Steroid Compounds and Treatment Methods
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071445 Combination Therapy for the Treatment of Multiple Myeloma
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071435 Pharmaceutical combinations comprising for the treatment of specific cancers
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 2211